merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The court ruling potentially impacts Ursula von der Leyen's chances of securing a second term by casting a shadow on her leadership and fueling criticism from opponents, particularly from the Greens, whose votes she may need to secure re-election.</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>The article suggests that Ursula von der Leyen's handling of the vaccine contracts has strained her relationships with center-left lawmakers, including the Greens, who have been critical of her secrecy and handling of the pandemic response.</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>The timing of the court's ruling might influence the upcoming vote on von der Leyen's future by highlighting her controversies and fueling opposition just before the vote.</answer>

<question_number>7</question_number>
<answer>The EU's vaccine procurement strategy under von der Leyen's leadership initially started slowly but later caught up and even surpassed other major countries, only to be criticized for ordering too many vaccines, resulting in some going to waste.</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>The court's ruling is connected to The New York Times' pending legal case as both involve issues of transparency and access to information related to the EU's vaccine procurement strategy.</answer>

<question_number>10</question_number>
<answer>N/A</answer>